These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38290426)

  • 1. Perspectives on Nuclear Magnetic Resonance Spectroscopy in Drug Discovery Research.
    Caceres-Cortes J; Falk B; Mueller L; Dhar TGM
    J Med Chem; 2024 Feb; 67(3):1701-1733. PubMed ID: 38290426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR spectroscopy: the swiss army knife of drug discovery.
    Horst R; Farley KA; Kormos BL; Withka JM
    J Biomol NMR; 2020 Nov; 74(10-11):509-519. PubMed ID: 32617727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting biomolecular NMR spectroscopy for promoting small-molecule drug discovery.
    Hanzawa H; Shimada T; Takahashi M; Takahashi H
    J Biomol NMR; 2020 Nov; 74(10-11):501-508. PubMed ID: 32306215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on NMR in drug discovery: a technique comes of age.
    Pellecchia M; Bertini I; Cowburn D; Dalvit C; Giralt E; Jahnke W; James TL; Homans SW; Kessler H; Luchinat C; Meyer B; Oschkinat H; Peng J; Schwalbe H; Siegal G
    Nat Rev Drug Discov; 2008 Sep; 7(9):738-45. PubMed ID: 19172689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR in structure-based drug design.
    Carneiro MG; Ab E; Theisgen S; Siegal G
    Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragment-based drug discovery using NMR spectroscopy.
    Harner MJ; Frank AO; Fesik SW
    J Biomol NMR; 2013 Jun; 56(2):65-75. PubMed ID: 23686385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding site identification and structure determination of protein-ligand complexes by NMR a semiautomated approach.
    Ziarek JJ; Peterson FC; Lytle BL; Volkman BF
    Methods Enzymol; 2011; 493():241-75. PubMed ID: 21371594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cells, drugs and NMR.
    Siegal G; Selenko P
    J Magn Reson; 2019 Sep; 306():202-212. PubMed ID: 31358370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of Solution NMR in Drug Discovery.
    Shi L; Zhang N
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33499337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR in drug discovery on membrane proteins.
    Wirmer-Bartoschek J; Bartoschek S
    Future Med Chem; 2012 May; 4(7):869-75. PubMed ID: 22571612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-Based Fluorine NMR Screening: Principles and Applications in Drug Discovery Projects.
    Dalvit C; Vulpetti A
    J Med Chem; 2019 Mar; 62(5):2218-2244. PubMed ID: 30295487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR approaches in structure-based lead discovery: recent developments and new frontiers for targeting multi-protein complexes.
    Dias DM; Ciulli A
    Prog Biophys Mol Biol; 2014; 116(2-3):101-12. PubMed ID: 25175337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical aspects of NMR-based fragment screening.
    Lepre CA
    Methods Enzymol; 2011; 493():219-39. PubMed ID: 21371593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The conformational musings of a medicinal chemist.
    Finch H
    Drug Discov Today; 2014 Mar; 19(3):320-5. PubMed ID: 24184532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Process of Fragment-Based Lead Discovery-A Perspective from NMR.
    Ma R; Wang P; Wu J; Ruan K
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27438813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
    Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
    J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paramagnetic NMR in drug discovery.
    Softley CA; Bostock MJ; Popowicz GM; Sattler M
    J Biomol NMR; 2020 Jul; 74(6-7):287-309. PubMed ID: 32524233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR in drug discovery: A practical guide to identification and validation of ligands interacting with biological macromolecules.
    Gossert AD; Jahnke W
    Prog Nucl Magn Reson Spectrosc; 2016 Nov; 97():82-125. PubMed ID: 27888841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments and applications of saturation transfer difference nuclear magnetic resonance (STD NMR) spectroscopy.
    Wagstaff JL; Taylor SL; Howard MJ
    Mol Biosyst; 2013 Apr; 9(4):571-7. PubMed ID: 23232937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.